{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:40:59Z","timestamp":1769182859232,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12011-017-0975-5","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T01:43:19Z","timestamp":1488764599000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis"],"prefix":"10.1007","volume":"179","author":[{"given":"Hongyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huangmei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"issue":"5","key":"975_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/em.21697","volume":"53","author":"Q Luo","year":"2012","unstructured":"Luo Q, Lai Y, Liu S, Wu M, Liu Y, Zhang Z (2012) Deregulated expression of DNA polymerase \u03b2 is involved in the progression of genomic instability. Environ Mol Mutagen 53(5):325\u2013333","journal-title":"Environ Mol Mutagen"},{"issue":"49","key":"975_CR2","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/sj.onc.1204762","volume":"20","author":"TD Zhang","year":"2001","unstructured":"Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z (2001) Arsenic trioxide, a therapeutic agent for APL. Oncogene 20(49):7146\u20137153","journal-title":"Oncogene"},{"issue":"2","key":"975_CR3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.canlet.2014.11.008","volume":"356","author":"S Dogra","year":"2014","unstructured":"Dogra S, Bandi S, Viswanathan P, Gupta S (2014) Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6\/E7 for further therapeutic directions in renal cell carcinoma. Cancer Lett 356(2):953\u2013961","journal-title":"Cancer Lett"},{"issue":"12","key":"975_CR4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/cas.12548","volume":"105","author":"H Ji","year":"2014","unstructured":"Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen J, Yang X (2014) Inhibition of transforming growth factor beta\/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer. Cancer Sci 105(12):1541\u20131549","journal-title":"Cancer Sci"},{"issue":"2","key":"975_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.toxlet.2014.03.016","volume":"227","author":"X Wang","year":"2014","unstructured":"Wang X, Jiang F, Mu J, Ye X, Si L, Ning S, Li Z, Li Y (2014) Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491. Toxicol Lett 227(2):75\u201383","journal-title":"Toxicol Lett"},{"issue":"3","key":"975_CR6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.etap.2013.08.002","volume":"36","author":"X Jiang","year":"2013","unstructured":"Jiang X, Chen C, Zhao W, Zhang Z (2013) Sodium arsenite and arsenic trioxide differently affect the oxidative stress, genotoxicity and apoptosis in A549 cells: an implication for the paradoxical mechanism. Environ Toxicol Pharmacol 36(3):891\u2013902","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"975_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1948-5956.1000379","volume":"8","author":"AM Walker","year":"2016","unstructured":"Walker AM, Stevens JJ, Ndebele K, Tchounwou PB (2016) Evaluation of arsenic trioxide potential for lung cancer treatment: assessment of apoptotic mechanisms and oxidative damage. J Cancer Sci Ther 8(1):1\u20139","journal-title":"J Cancer Sci Ther"},{"issue":"5","key":"975_CR8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.bjc.6690766","volume":"81","author":"C Yang","year":"1999","unstructured":"Yang C, Kuo M, Chen J, Chen Y (1999) Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Br J Cancer 81(5):796\u2013799","journal-title":"Br J Cancer"},{"key":"975_CR9","doi-asserted-by":"crossref","first-page":"29865","DOI":"10.1038\/srep29865","volume":"6","author":"XY Fan","year":"2016","unstructured":"Fan XY, Chen XY, Liu YJ, Zhong HM, Jiang FL, Liu Y (2016) Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals. Sci Rep 6:29865","journal-title":"Sci Rep"},{"key":"975_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9361-3","author":"MV Varghese","year":"2016","unstructured":"Varghese MV, Abhilash M, Paul MV, Alex M, Nair RH (2016) Omega-3 fatty acid protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Cardiovasc Toxicol. doi: 10.1007\/s12012-016-9361-3","journal-title":"Cardiovasc Toxicol"},{"issue":"19","key":"975_CR11","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1200\/JCO.2003.10.009","volume":"21","author":"JT Barbey","year":"2003","unstructured":"Barbey JT, Pezzullo JC, Soignet SL (2003) Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 21(19):3609\u20133615","journal-title":"J Clin Oncol"},{"issue":"2","key":"975_CR12","first-page":"e67","volume":"35","author":"L Hao","year":"2013","unstructured":"Hao L, Zhao J, Wang X, Wang H, Wang H, Xu G (2013) Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia. J Pediatr Hematol Oncol 35(2):e67\u2013e70","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"975_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1016270206374","volume":"20","author":"J Vuky","year":"2002","unstructured":"Vuky J, Yu R, Schwartz L, Motzer RJ (2002) Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Investig New Drugs 20(3):327\u2013330","journal-title":"Investig New Drugs"},{"issue":"2","key":"975_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.V98.2.266","volume":"98","author":"P Westervelt","year":"2001","unstructured":"Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, Di Persio JF (2001) Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 98(2):266\u2013271","journal-title":"Blood"},{"key":"975_CR15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12041","author":"J Song","year":"2016","unstructured":"Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J (2016) Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo. Oncotarget. doi: 10.18632\/oncotarget.12041","journal-title":"Oncotarget"},{"key":"975_CR16","doi-asserted-by":"crossref","first-page":"31664","DOI":"10.1038\/srep31664","volume":"6","author":"HL Huang","year":"2016","unstructured":"Huang HL, Chao MW, Li YC, Chang LH, Chen CH, Chen MC, Cheng CC, Liou JP, Teng CM, Pan SL (2016) MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JKN-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer. Sci Rep 6:31664","journal-title":"Sci Rep"},{"issue":"6","key":"975_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14786410310001620556","volume":"18","author":"D Sriram","year":"2004","unstructured":"Sriram D, Rao VS, Chandrasekhara KV, Yogeeswari P (2004) Progress in the research of artemisinin and its analogues as antimalarials: an update. Nat Prod Res 18(6):503\u2013527","journal-title":"Nat Prod Res"},{"issue":"4","key":"975_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0024-3205(99)00356-2","volume":"66","author":"V Dhingra","year":"2000","unstructured":"Dhingra V, Vishweshwar Rao K, Lakshmi Narasu M (2000) Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci 66(4):279\u2013300","journal-title":"Life Sci"},{"issue":"1","key":"975_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","volume":"293","author":"SJ Wang","year":"2010","unstructured":"Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B (2010) Dihydroartemisinin inactivates NF-kB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 293(1):99\u2013108","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"975_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0716-6","volume":"351","author":"Y Ji","year":"2011","unstructured":"Ji Y, Zhang YC, Pei LB, Shi LL, Yan JL, Ma XH (2011) Anti-tumor effects of dihydroartemisinin on human osteosarcoma. Mol Cell Biochem 351(1\u20132):99\u2013108","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"975_CR21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/030089161109700615","volume":"97","author":"X Gao","year":"2011","unstructured":"Gao X, Luo Z, Xiang T, Wang K, Li J, Wang P (2011) Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells. Tumori 97(6):771\u2013780","journal-title":"Tumori"},{"issue":"1","key":"975_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","volume":"91","author":"H Lai","year":"1995","unstructured":"Lai H, Singh NP (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91(1):41\u201346","journal-title":"Cancer Lett"},{"issue":"11","key":"975_CR23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.lfs.2004.08.020","volume":"76","author":"H Lai","year":"2005","unstructured":"Lai H, Sasaki T, Singh NP, Messay A (2005) Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 76(11):1267\u20131279","journal-title":"Life Sci"},{"issue":"7","key":"975_CR24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1582-4934.2008.00360.x","volume":"13","author":"T Chen","year":"2009","unstructured":"Chen T, Li M, Zhang RW, Wang H (2009) Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med 13(7):1358\u20131370","journal-title":"J Cell Mol Med"},{"issue":"4","key":"975_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10495-013-0953-0","volume":"19","author":"C Zhao","year":"2014","unstructured":"Zhao C, Gao W, Chen T (2014) Synergistic induction of apoptosis in A549 cells by hidydroartemisinin and gemcitabine. Apoptosis 19(4):668\u2013681","journal-title":"Apoptosis"},{"issue":"10","key":"975_CR26","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.cellsig.2014.07.001","volume":"26","author":"C Zhao","year":"2014","unstructured":"Zhao C, Qin G, Gao W, Chen J, Liu H, Xi G, Li T, Wu S, Chen T (2014) Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells. Cell Signal 26(10):2223\u20132233","journal-title":"Cell Signal"},{"issue":"14","key":"975_CR27","first-page":"3893","volume":"62","author":"WH Miller","year":"2002","unstructured":"Miller WH, Schipper HM, Lee JS, Singer J, Waxman S (2002) Mechanisms of action of arsenic trioxide. Cancer Res 62(14):3893\u20133903","journal-title":"Cancer Res"},{"issue":"9","key":"975_CR28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2004.01.011","volume":"28","author":"AM Evens","year":"2004","unstructured":"Evens AM, Tallman MS, Gartenhaus RB (2004) The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leuk Res 28(9):891\u2013900","journal-title":"Leuk Res"},{"issue":"22","key":"975_CR29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2174\/092986708785747526","volume":"15","author":"X Cui","year":"2008","unstructured":"Cui X, Kobayashi Y, Akashi M, Okayasu R (2008) Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer. Curr Med Chem 15(22):2293\u20132304","journal-title":"Curr Med Chem"},{"issue":"2","key":"975_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.freeradbiomed.2011.04.008","volume":"51","author":"SJ Flora","year":"2011","unstructured":"Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51(2):257\u2013281","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"975_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","volume":"31","author":"H Lai","year":"2013","unstructured":"Lai H, Singh NP, Sasaki T (2013) Development of artemisinin compounds for cancer treatment. Investig New Drugs 31(1):230\u2013246","journal-title":"Investig New Drugs"},{"issue":"12","key":"975_CR32","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","volume":"68","author":"R Dell\u2019Eva","year":"2004","unstructured":"Dell\u2019Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Inhibition of angiogenesis in vivo and growth of Kaposi\u2019s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68(12):2359\u20132366","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"975_CR33","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","volume":"65","author":"GL Disbrow","year":"2005","unstructured":"Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res 65(23):10854\u201310861","journal-title":"Cancer Res"},{"issue":"4","key":"975_CR34","first-page":"2277","volume":"24","author":"NP Singh","year":"2004","unstructured":"Singh NP, Lai H (2004) Artemisinin induces apoptosis in human cancer cells. Anticancer Res 24(4):2277\u20132280","journal-title":"Anticancer Res"},{"issue":"2","key":"975_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00280-005-0002-y","volume":"57","author":"J Lee","year":"2006","unstructured":"Lee J, Zhou HJ, Wu XH (2006) Dihydroartemisinin down regulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemoth Pharm 57(2):213\u2013220","journal-title":"Cancer Chemoth Pharm"},{"issue":"13","key":"975_CR36","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1074\/jbc.M610375200","volume":"282","author":"AE Mercer","year":"2007","unstructured":"Mercer AE, Maggs JL, Sun XM, Cohen GM, Chadwick J, O\u2019Neill PM, Park BK (2007) Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem 282(13):9372\u20139382","journal-title":"J Biol Chem"},{"key":"975_CR37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cbi.2016.01.005","volume":"245","author":"S Gu","year":"2016","unstructured":"Gu S, Chen C, Jiang X, Zhang Z (2016) ROS-mediated endoplasmic stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells. Chem Biol Interact 245:100\u2013109","journal-title":"Chem Biol Interact"},{"key":"975_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-8722-3-28","volume":"3","author":"C Yedjou","year":"2010","unstructured":"Yedjou C, Tchounwou P, Jenkins J, McMurray R (2010) Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol 3:28. doi: 10.1186\/1756-8722-3-28","journal-title":"J Hematol Oncol"},{"issue":"8","key":"975_CR39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-015-1132-2","volume":"20","author":"G Qin","year":"2015","unstructured":"Qin G, Zhao C, Zhang L, Liu H, Quan Y, Chai L, Wu S, Wang X, Chen T (2015) Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells. Apoptosis 20(8):1072\u20131086","journal-title":"Apoptosis"},{"issue":"12","key":"975_CR40","first-page":"8684","volume":"7","author":"K Liao","year":"2014","unstructured":"Liao K, Li J, Wang Z (2014) Dihydroartemisinin inhibits cell proliferation via AKT\/GSK3\u03b2\/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells. Int J Clin Exp Pathol 7(12):8684\u20138691","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"975_CR41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cll.2006.12.008","volume":"27","author":"PG Wylie","year":"2007","unstructured":"Wylie PG, Bowen WP (2007) Determination of cell colony formation in a high content screening assay. Clin Lab Med 27(1):193\u2013199","journal-title":"Clin Lab Med"},{"issue":"3","key":"975_CR42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","volume":"35","author":"RR Tice","year":"2000","unstructured":"Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206\u2013221","journal-title":"Environ Mol Mutagen"},{"issue":"3","key":"975_CR43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2106\/00004623-199603000-00007","volume":"78","author":"H Takeshita","year":"1996","unstructured":"Takeshita H, Gebhardt MC, Springfield DS, Kusuzaki K, Mankin HJ (1996) Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. J Bone Joint Surg Am 78(3):366\u2013375","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"975_CR44","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/15384047.2015.1071738","volume":"16","author":"B Wang","year":"2015","unstructured":"Wang B, Hou D, Liu Q, Wu T, Guo H, Zhang X, Zou Y, Liu Z, Liu J, Wei J, Gong Y, Shao C (2015) Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51. Cancer Biol Ther 16(10):1548\u20131556","journal-title":"Cancer Biol Ther"},{"key":"975_CR45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","volume":"70","author":"H Lai","year":"2001","unstructured":"Lai H, Singh NP (2001) Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70:49\u201356","journal-title":"Life Sci"},{"issue":"4\u20135","key":"975_CR46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2010.04.001","volume":"24","author":"A Emadi","year":"2010","unstructured":"Emadi A, Gore SD (2010) Arsenic trioxide\u2014an old drug rediscovered. Blood Rev 24(4\u20135):191\u2013199","journal-title":"Blood Rev"},{"key":"975_CR47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cbi.2014.12.007","volume":"226","author":"Q Luo","year":"2015","unstructured":"Luo Q, Li Y, Deng J, Zhang Z (2015) PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G 2\/M checkpoint and suppression of DNA damage repair. Chem Biol Interact 226:12\u201322","journal-title":"Chem Biol Interact"},{"issue":"15","key":"975_CR48","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1096\/fj.02-0093fje","volume":"17","author":"N Mei","year":"2003","unstructured":"Mei N, Lee J, Sun X, Xing JZ, Hanson J, Le XC, Weinfeld M (2003) Genetic predisposition to the cytotoxicity of arsenic: the role of DNA damage and ATM. FASEB J 17(15):2310\u20132312","journal-title":"FASEB J"},{"issue":"5","key":"975_CR49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.freeradbiomed.2004.02.003","volume":"37","author":"TK Hei","year":"2004","unstructured":"Hei TK, Filipic M (2004) Role of oxidative damage in the genotoxicity of arsenic. Free Radic Biol Med 37(5):574\u2013581","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"975_CR50","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2011-01-330050","volume":"118","author":"T Yahata","year":"2011","unstructured":"Yahata T, Takanashi T, Muguruma Y, Ibrahim AA, Matsuzawa H, Uno T, Sheng Y, Onizuka M, Ito M, Kato S, Ando K (2011) Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 118(11):2941\u20132950","journal-title":"Blood"},{"key":"975_CR51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0300-483X(02)00460-2","volume":"181-182","author":"JA Pietenpol","year":"2002","unstructured":"Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182:475\u2013481","journal-title":"Toxicology"},{"issue":"1","key":"975_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.04.022","volume":"516","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Cao EH, Qin JF (2005) Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells. Eur J Pharmacol 516(1):1\u20139","journal-title":"Eur J Pharmacol"},{"key":"975_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4939-0888-2_3","volume":"1170","author":"K Beishline","year":"2014","unstructured":"Beishline K, Azizkhan-Clifford J (2014) Interplay between the cell cycle and double-strand break response in mammalian cells. Methods Mol Biol 1170:41\u201359","journal-title":"Methods Mol Biol"},{"issue":"2","key":"975_CR54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2013.01.011","volume":"138","author":"S Diaz-Moralli","year":"2013","unstructured":"Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, Cascante M (2013) Targeting cell cycle regulation in cancer therapy. Pharmacol Ther 138(2):255\u2013271","journal-title":"Pharmacol Ther"},{"issue":"14","key":"975_CR55","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1158\/0008-5472.CAN-13-3604","volume":"74","author":"T Hirokawa","year":"2014","unstructured":"Hirokawa T, Shiotani B, Shimada M, Murata K, Johmura Y, Haruta M, Tahara H, Takeyama H, Nakanishi M (2014) CBP-93872 inhibits NBS1-mediated ATR activation, abrogating maintenance of the DNA double-strand break-specific G 2 checkpoint. Cancer Res 74(14):3880\u20133889","journal-title":"Cancer Res"},{"issue":"14","key":"975_CR56","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jnci\/88.14.956","volume":"88","author":"Q Wang","year":"1996","unstructured":"Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O\u2019Connor PM (1996) UCN-01: a potent abrogator of G 2 checkpoint function in cancer cells with disrupted p53. J Nati Cancer Inst 88(14):956\u2013965","journal-title":"J Nati Cancer Inst"},{"issue":"6835","key":"975_CR57","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366\u2013374","journal-title":"Nature"},{"issue":"9","key":"975_CR58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","volume":"12","author":"WP Roos","year":"2006","unstructured":"Roos WP, Kaina B (2006) DNA damage-induced cell death by apoptosis. Trends Mol Med 12(9):440\u2013450","journal-title":"Trends Mol Med"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-017-0975-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-017-0975-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-017-0975-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T09:25:25Z","timestamp":1568885125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-017-0975-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1007\/s12011-017-0975-5","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}